Lu X - Search Results

1

Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19.

Tschirhart BJ, Lu X, Mokale Kognou AL, Martin CM, Slessarev M, Fraser DD, Leligdowicz A, Urquhart B, Feng Q. Tschirhart BJ, et al. Among authors: lu x. Front Pharmacol. 2024 Jan 10;14:1299613. doi: 10.3389/fphar.2023.1299613. eCollection 2023. Front Pharmacol. 2024. PMID: 38269269 Free PMC article.

2

Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility Trial.

Martin CM, Slessarev M, Campbell E, Basmaji J, Ball I, Fraser DD, Leligdowicz A, Mele T, Priestap F, Tschirhart BJ, Bentall T, Lu X, Feng Q. Martin CM, et al. Among authors: lu x. Crit Care Explor. 2023 Oct 5;5(10):e0986. doi: 10.1097/CCE.0000000000000986. eCollection 2023 Oct. Crit Care Explor. 2023. PMID: 37811130 Free PMC article.

3

Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding.

Tschirhart BJ, Lu X, Gomes J, Chandrabalan A, Bell G, Hess DA, Xing G, Ling H, Burger D, Feng Q. Tschirhart BJ, et al. Among authors: lu x. Pharmaceuticals (Basel). 2023 Jun 3;16(6):837. doi: 10.3390/ph16060837. Pharmaceuticals (Basel). 2023. PMID: 37375784 Free PMC article.

4

Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia.

Arnold P, Lu X, Amirahmadi F, Brandl K, Arnold JM, Feng Q. Arnold P, et al. Among authors: lu x. Crit Care Med. 2014 Jan;42(1):e32-41. doi: 10.1097/CCM.0b013e3182a63e01. Crit Care Med. 2014. PMID: 24145837

5

Inhibition of intraflagellar transport protein-88 promotes epithelial-to-mesenchymal transition and reduces cardiac remodeling post-myocardial infarction.

Blom JN, Wang X, Lu X, Kim MY, Wang G, Feng Q. Blom JN, et al. Among authors: lu x. Eur J Pharmacol. 2022 Oct 15;933:175287. doi: 10.1016/j.ejphar.2022.175287. Epub 2022 Sep 20. Eur J Pharmacol. 2022. PMID: 36150531

6

Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis.

Zhao X, Lu X, Feng Q. Zhao X, et al. Among authors: lu x. Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2371-8. doi: 10.1152/ajpheart.00383.2002. Epub 2002 Aug 22. Am J Physiol Heart Circ Physiol. 2002. PMID: 12388304 Free article.

7

NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes.

Peng T, Lu X, Feng Q. Peng T, et al. Among authors: lu x. FASEB J. 2005 Feb;19(2):293-5. doi: 10.1096/fj.04-2289fje. Epub 2004 Nov 16. FASEB J. 2005. PMID: 15546960

8

Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression.

Peng T, Lu X, Feng Q. Peng T, et al. Among authors: lu x. Circulation. 2005 Apr 5;111(13):1637-44. doi: 10.1161/01.CIR.0000160366.50210.E9. Epub 2005 Mar 28. Circulation. 2005. PMID: 15795323

9

Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury.

Xiang FL, Lu X, Liu Y, Feng Q. Xiang FL, et al. Among authors: lu x. Int J Cardiol. 2013 Oct 9;168(4):3486-94. doi: 10.1016/j.ijcard.2013.04.165. Epub 2013 May 13. Int J Cardiol. 2013. PMID: 23680593

10

Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development.

Leung C, Lu X, Liu M, Feng Q. Leung C, et al. Among authors: lu x. J Am Heart Assoc. 2014 Oct 14;3(5):e001271. doi: 10.1161/JAHA.114.001271. J Am Heart Assoc. 2014. PMID: 25315346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,692 results

Search Page

Filters